SLC39A14 and Parkinson disease: In 2016, bi-allelic mutations in SLC39A14 were identified in individuals with features of Mn neurotoxicity, such as rapidly progressing dystonia, variable parkinsonism, and T1 hyperintensity in the globus pallidus observed on brain MRI [45].